Abstract
Despite efforts to promote development of therapies for rare diseases, the number of available treatments remains low and progress is too slow to have a significant impact on patients. This does not necessarily reflect a lack of interest in rare disease research, and significant efforts have been made toward the development and clinical testing of molecular therapies for these diseases. The intrinsic challenges of understanding the mechanisms underlying rare diseases render the design of efficacious therapies laborious.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
